This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Big-Volume Stocks Surging Higher

Affymax

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Affymax (AFFY) is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. This stock is trading up 5% at $17.81 in recent trading.

Today's Volume: 1.2 million

Average Volume: 1

Volume % Change: 130%

>>5 Stocks Poised for Breakouts

From a technical perspective, AFFY is ripping higher here right off some near-term support at $17 with above average volume. This move has also pushed AFFY into breakout territory, since the stock has taken out some near-term overhead resistance levels at $17.16 to $17.33. This move has also pushed AFFY into new 52-week high territory, which is bullish technical price action.

Traders should continue to look for long-biased traders as long as AFFY is trending above today's low of $16.95 with strong upside volume flows. I would consider any upside volume day that registers near or above 1 million shares as bullish. If AFFY can hold that trend, then this stock has a great chance of hitting $20 in the near future.

I also featured AFFY earlier this month in " 5 Hated Stocks Set to Soar on Earnings."
4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FRAN $11.10 2.45%
ISBC $11.75 1.56%
RPRX $7.20 2.86%
AFFY $0.09 11.54%
AAPL $111.88 2.00%

Markets

Chart of I:DJI
DOW 16,654.77 +369.26 2.27%
S&P 500 1,987.66 +47.15 2.43%
NASDAQ 4,812.7080 +115.1720 2.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs